ICON plc | Clinical Research Organisation (CRO) for Drug Development

Webinar: Successful Digital Trial Template

Explore the best practices for implementing a successful digital trial.

Considerations for Parkinson’s Disease Trials

Aspects of Parkinson’s Disease studies that sponsors should bear in mind as they plan their clinical trials.

Increasing site and patient compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

01 July 2020

Juvenile Arthritis Awareness Month: This fight is personal

This blog is a condensed version of an ICON employee’s’ personal journey of courage and endurance.

24 June 2020

Enabling clinical development of cell and gene therapies on a global basis

In a recent podcast interview, ICON experts discuss the intricacies of CGT development, the solutions that will enable CGT development on a global basis, and the future of CGT clinical trials.

02 June 2020

Improving access and reimbursement for specialty therapies

Clinical development can better satisfy the evidence needs of payers, and not incorporating the needs of payers early into trial designs risks the need to spend more money later on.

29 May 2020

The differences between the US and EU biosimilar markets

Biosimilar uptake in the US market has, until now, stood in stark contrast to that in the EU, which has led the way in biosimilar approvals and use since 2006.

05 May 2020

How to ensure your trial data and patients remain safe during COVID-19

The COVID-19 pandemic has presented an array of cybersecurity challenges. With no slowing down of the virus’s spread, hackers and other cyber criminals are continuing to seize opportunities to take advantage of vulnerable networks.

29 April 2020

The impact of COVID-19 on pharmacovigilance

COVID-19 is affecting how clinical trials are managed, in terms of patient recruitment, patient care, data collection, analysis and safety reporting.

29 April 2020

Wearables and digital endpoint generation

The key considerations that arise when using digital technology to support endpoint generation in clinical studies.

27 April 2020

The shifting diagnostics regulatory landscape amid COVID-19

For IVD manufacturers, the emergence of a novel virus is challenging as the detection of such viruses require quickly developed, novel diagnostic solutions.

20 April 2020

Five common literature reviews for RWE generation

In the evidence-based era of medicine and decision-making, literature reviews offer a faster and more cost-efficient method to gather intelligence.

サービス

治療領域

イノベーション

業界を見通すインサイト

ニュース & イベント

アイコンについて

Precision Medicine

Value Based Healthcare

Improving Pharma R&D Efficiency

CDISC Data Standardisation